Responses
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015Author's replyShow More
Dear Editor,
We appreciate the comments made by Kasikcioglu and Dickerman concerning our published study. [1] The assumption of “hypertrophic cardiomyopathy”-like myocardial changes and the difficulty of assessment of these changes is also supported by our recent findings pointing to a reduced diastolic function in bodybuilders with anabolic steroid abuse by using cardiac tissue doppler imaging, while conventio...
Conflict of Interest:
None declared. - Published on: 23 November 2015Cardiac Maladaptation in athletes using anabolic steroidesShow More
Dear Editor
I read with great interest the published study by Urhausen et al. [1] It is known that anabolic steroid use in athletes has become a major medical issue. Although Urhausen et al. found that left ventricular wall thickness related to fat-free body mass did not differ between users and ex-users, Sachtleben et al. [2] previously reported that the parameters of left ventricular thickness showed si...
Conflict of Interest:
None declared. - Published on: 23 November 2015Re: Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?Show More
Dear Editor
I read the article by Urhausen et al. “Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?” with great interest, however there are several factors that should be discussed.[1]
First, the only subjects with left ventricular posterior wall measurements beyond normal limits were the users, which were only slightly enlarged >11.4 mm. We previously reported on...
Conflict of Interest:
None declared.